Trial intelligence / Profile preview

Vigilance regulation as predictor of response to Psychostimulants in adult patients with ADHD

DRKS00009971Phase 4Completed

Sponsor
Leipzig University
Start
Jan 2016
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of methylphenidate in attention deficit hyperactivity disorder (ADHD), sponsored by Leipzig University. Started Jan 2016; status: completed.

02

Drugs

methylphenidate
03

Conditions

attention deficit hyperactivity disorder (ADHD)

Beyond the preview

Go deeper on DRKS00009971.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on DRKS00009971.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call